|
WO1996009818A1
(en)
|
1994-09-27 |
1996-04-04 |
Merck & Co., Inc. |
Endothelin receptor antagonists for the treatment of emesis
|
|
US5939431A
(en)
*
|
1996-06-20 |
1999-08-17 |
Schering Corporation |
Naphthyridines which affect IL-4 and G-CSF
|
|
TW520362B
(en)
|
1996-12-05 |
2003-02-11 |
Amgen Inc |
Substituted pyrimidine compounds and pharmaceutical composition comprising same
|
|
SE0102439D0
(sv)
|
2001-07-05 |
2001-07-05 |
Astrazeneca Ab |
New compounds
|
|
WO2003087044A2
(en)
|
2002-04-09 |
2003-10-23 |
7Tm Pharma A/S |
Novel carboxamide compounds for use in mch receptor related disorders
|
|
AU2003286876A1
(en)
|
2002-11-01 |
2004-06-07 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of jak and other protein kinases
|
|
CA2514733A1
(en)
|
2003-02-28 |
2004-09-16 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
|
|
US20040204422A1
(en)
|
2003-04-14 |
2004-10-14 |
Abbott Gmbh & Co. Kg. |
N-[(Piperazinyl)hetaryl]arylsulfonamide compounds
|
|
SE0301654D0
(sv)
*
|
2003-06-05 |
2003-06-05 |
Astrazeneca Ab |
Novel compounds
|
|
US7504401B2
(en)
|
2003-08-29 |
2009-03-17 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
|
WO2005040135A1
(ja)
|
2003-10-24 |
2005-05-06 |
Ono Pharmaceutical Co., Ltd. |
抗ストレス薬およびその医薬用途
|
|
PE20060285A1
(es)
|
2004-03-30 |
2006-05-08 |
Aventis Pharma Inc |
Piridonas sustituidas como inhibidores de pol(adp-ribosa)-polimerasa (parp)
|
|
WO2005103022A1
(en)
|
2004-04-20 |
2005-11-03 |
Transtech Pharma, Inc. |
Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators
|
|
FR2874011B1
(fr)
|
2004-08-03 |
2007-06-15 |
Sanofi Synthelabo |
Derives de sulfonamides, leur preparation et leur application en therapeutique
|
|
CA2576993C
(en)
|
2004-08-12 |
2013-09-24 |
Amgen Inc. |
Bisaryl-sulfonamides
|
|
CA2582276C
(en)
|
2004-10-04 |
2011-09-13 |
F. Hoffmann-La Roche Ag |
Alkil-pyridines as 11-beta inhibitors for diabetes
|
|
EP1666467A1
(en)
|
2004-11-08 |
2006-06-07 |
Evotec AG |
11Beta-HSD1 Inhibitors
|
|
SE0402735D0
(sv)
|
2004-11-09 |
2004-11-09 |
Astrazeneca Ab |
Novel compounds
|
|
WO2006106423A2
(en)
|
2005-04-07 |
2006-10-12 |
Pfizer Inc. |
Amino sulfonyl derivatives as inhibitors of human 11-.beta.-hydrosysteroid dehydrogenase
|
|
EP1922068A4
(en)
|
2005-08-16 |
2010-08-11 |
Icagen Inc |
INHIBITORS OF VOLTAGE-CONTROLLED SODIUM CHANNELS
|
|
AU2006283944A1
(en)
|
2005-08-25 |
2007-03-01 |
F. Hoffmann-La Roche Ag |
P38 MAP kinase inhibitors and methods for using the same
|
|
FR2896798A1
(fr)
|
2006-01-27 |
2007-08-03 |
Sanofi Aventis Sa |
Derives de sulfonamides, leur preparation et leur application en therapeutique
|
|
WO2007129044A1
(en)
|
2006-05-03 |
2007-11-15 |
Astrazeneca Ab |
Thiazole derivatives and their use as anti-tumour agents
|
|
US20080280891A1
(en)
|
2006-06-27 |
2008-11-13 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
|
US8519135B2
(en)
|
2006-07-14 |
2013-08-27 |
Chemocentryx, Inc. |
Heteroaryl sulfonamides and CCR2/CCR9
|
|
EP2049515B1
(en)
|
2006-07-14 |
2011-01-26 |
ChemoCentryx, Inc. |
Triazolyl pyridyl benzenesulfonamides as ccr2 or ccr9 modulators for the treatment of atherosclerosis
|
|
DK2420494T3
(en)
|
2006-08-16 |
2015-01-12 |
J David Gladstone Inst A Testamentary Trust Established Under The Will Of J David Gladstone |
Use of thiadiazole compounds as inhibitors of kynurenine 3-monooxygenase
|
|
AU2007293653B2
(en)
|
2006-09-08 |
2011-02-17 |
Novartis Ag |
N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions
|
|
WO2008033455A2
(en)
|
2006-09-13 |
2008-03-20 |
The Institutes For Pharmaceutical Discovery, Llc |
Biphenyl and heteroaryl phenyl derivatives as protein tyrosine phosphatases inhibitors
|
|
US8084454B2
(en)
|
2007-04-11 |
2011-12-27 |
Canbas Co., Ltd. |
Compounds with anti-cancer activity
|
|
WO2008157500A1
(en)
|
2007-06-17 |
2008-12-24 |
Kalypsys, Inc. |
Aminoquinazoline cannabinoid receptor modulators for treatment of disease
|
|
WO2009011850A2
(en)
|
2007-07-16 |
2009-01-22 |
Abbott Laboratories |
Novel therapeutic compounds
|
|
EP2211615A4
(en)
|
2007-10-22 |
2010-10-13 |
Glaxosmithkline Llc |
PYRIDOSULFONAMIDE DERIVATIVES AS PI3 KINASE INHIBITORS
|
|
CA2714232A1
(en)
|
2008-02-05 |
2009-08-13 |
Pfizer Inc. |
Pyridinyl amides for the treatment of cns and metabolic disorders
|
|
EA201001847A1
(ru)
|
2008-06-11 |
2011-08-30 |
Айрм Ллк |
Соединения и композиции, применяемые для лечения малярии
|
|
WO2010029300A1
(en)
|
2008-09-12 |
2010-03-18 |
Biolipox Ab |
Bis aromatic compounds for use in the treatment of inflammation
|
|
WO2010100475A1
(en)
|
2009-03-02 |
2010-09-10 |
Astrazeneca Ab |
Hydroxamic acid derivatives as gram-negative antibacterial agents
|
|
EP2421368A4
(en)
*
|
2009-04-20 |
2013-01-09 |
Inst Oneworld Health |
COMPOUNDS, COMPOSITIONS AND METHODS FOR PYRIDAZINE SULFONAMIDE DERIVATIVES
|
|
EP2253617A1
(de)
|
2009-05-20 |
2010-11-24 |
Bayer CropScience AG |
Halogen-substituierte Verbindungen als Pestizide
|
|
US20130022629A1
(en)
|
2010-01-04 |
2013-01-24 |
Sharpe Arlene H |
Modulators of Immunoinhibitory Receptor PD-1, and Methods of Use Thereof
|
|
PH12012502551A1
(en)
|
2010-06-28 |
2017-08-23 |
Bayer Ip Gmbh |
Heterocyclic compounds as agents for pest control
|
|
WO2012004293A2
(de)
|
2010-07-08 |
2012-01-12 |
Bayer Cropscience Ag |
Insektizide und fungizide wirkstoffkombinationen
|
|
CA2822789A1
(en)
|
2010-12-22 |
2012-06-28 |
Purdue Pharma L.P. |
Substituted pyridines as sodium channel blockers
|
|
WO2012125904A1
(en)
|
2011-03-17 |
2012-09-20 |
The Trustees Of The University Of Pennsylvania |
Mutation mimicking compounds that bind to the kinase domain of egfr
|
|
US9056867B2
(en)
*
|
2011-09-16 |
2015-06-16 |
Novartis Ag |
N-substituted heterocyclyl carboxamides
|
|
WO2013134562A1
(en)
*
|
2012-03-09 |
2013-09-12 |
Inception 2, Inc. |
Triazolone compounds and uses thereof
|
|
WO2014028968A1
(en)
|
2012-08-21 |
2014-02-27 |
Peter Maccallum Cancer Institute |
Perforin inhibiting benzenesulfonamide compounds, preparation and uses thereof
|
|
WO2014031928A2
(en)
|
2012-08-24 |
2014-02-27 |
Philip Jones |
Heterocyclic modulators of hif activity for treatment of disease
|
|
WO2014160478A1
(en)
|
2013-03-13 |
2014-10-02 |
Flatley Discovery Lab |
Compounds and methods for the treatment of cystic fibrosis
|
|
WO2014181287A1
(en)
|
2013-05-09 |
2014-11-13 |
Piramal Enterprises Limited |
Heterocyclyl compounds and uses thereof
|
|
WO2015097122A1
(en)
|
2013-12-23 |
2015-07-02 |
Norgine B.V. |
Benzene sulfonamides as ccr9 inhibitors
|
|
EP3116870A1
(en)
*
|
2014-03-13 |
2017-01-18 |
Proteostasis Therapeutics, Inc. |
Compounds, compositions, and methods for increasing cftr activity
|
|
EP3798214B1
(en)
|
2014-10-06 |
2022-09-14 |
Vertex Pharmaceuticals Incorporated |
Modulators of cystic fibrosis transmembrane conductance regulator
|
|
CN104844566B
(zh)
|
2014-12-12 |
2018-05-18 |
合肥中科普瑞昇生物医药科技有限公司 |
一种新型结构的激酶抑制剂
|
|
CN107922338A
(zh)
*
|
2015-06-02 |
2018-04-17 |
艾伯维公司 |
经取代的吡啶及使用方法
|
|
US9981945B2
(en)
|
2015-10-07 |
2018-05-29 |
NuBridge BioSciences |
Pyrimidine derivatives as CFTR modulators
|
|
GB201602527D0
(en)
*
|
2016-02-12 |
2016-03-30 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
|
EP3436446B1
(en)
|
2016-03-31 |
2023-06-07 |
Vertex Pharmaceuticals Incorporated |
Modulators of cystic fibrosis transmembrane conductance regulator
|
|
TW201811766A
(zh)
*
|
2016-08-29 |
2018-04-01 |
瑞士商諾華公司 |
N-(吡啶-2-基)吡啶-磺醯胺衍生物及其用於疾病治療之用途
|